We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+14.45%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.83B
AUM Growth
-$23.2M
Cap. Flow
-$201M
Cap. Flow %
-10.94%
Top 10 Hldgs %
24.61%
Holding
261
New
14
Increased
25
Reduced
199
Closed
13

Top Buys

Rank Stock Value
1
SRAD icon
Sportradar
SRAD
+$23.7M
2
FOUR icon
Shift4
FOUR
+$22.6M
3
PRGS icon
Progress Software
PRGS
+$9.32M
4
QDEL icon
QuidelOrtho
QDEL
+$7.08M
5
VRDN icon
Viridian Therapeutics
VRDN
+$6.06M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$58.7M
2
WNS
WNS Holdings
WNS
+$46.2M
3
TKO icon
TKO Group
TKO
+$23.8M
4
WLDN icon
Willdan Group
WLDN
+$8.81M
5
EEFT icon
Euronet Worldwide
EEFT
+$7.12M

Sector Composition

Rank Sector Weight
1 Healthcare 32.04%
2 Technology 28.06%
3 Industrials 17.55%
4 Consumer Discretionary 6.84%
5 Communication Services 5.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TDY icon
201
Teledyne Technologies
TDY
$32.2B
$1.03M 0.06%
1,753
-56
-3% -$30.7K
SNWV
202
SANUWAVE Health Inc
SNWV
$48.1M
$1.02M 0.06%
+27,302
New +$1.01M
HLX icon
203
Helix Energy Solutions
HLX
$1.46B
$1.02M 0.06%
155,247
-98,608
-39% -$621K
SLP icon
204
Simulations Plus
SLP
$371M
$996K 0.05%
66,086
-31,549
-32% -$459K
DOV icon
205
Dover
DOV
$28.3B
$978K 0.05%
5,862
-14
-0.2% -$2.51K
MLTX icon
206
MoonLake Immunotherapeutics
MLTX
$1.46B
$967K 0.05%
134,835
-7,485
-5% -$390K
EB
207
DELISTED
Eventbrite
EB
$947K 0.05%
375,855
-967,644
-72% -$2.53M
GDYN icon
208
Grid Dynamics Holdings
GDYN
$622M
$909K 0.05%
117,940
-56,099
-32% -$501K
EBAY icon
209
eBay
EBAY
$48.2B
$846K 0.05%
9,305
-22
-0.2% -$1.95K
EXEL icon
210
Exelixis
EXEL
$13.1B
$834K 0.05%
20,199
-558
-3% -$22.4K
ABT icon
211
Abbott
ABT
$188B
$808K 0.04%
6,029
-150
-2% -$19.7K
BRK.A icon
212
Berkshire Hathaway Class A
BRK.A
$1.15T
$754K 0.04%
1
– –
BTMD icon
213
Biote Corp
BTMD
$44.3M
$681K 0.04%
227,024
+105,369
+87% +$376K
CR icon
214
Crane Co
CR
$12.7B
$652K 0.04%
3,542
-41
-1% -$7.73K
JPM icon
215
JPMorgan Chase
JPM
$950B
$621K 0.03%
1,970
– –
AAPL icon
216
Apple
AAPL
$4.48T
$607K 0.03%
2,385
– –
SCPH
217
DELISTED
scPharmaceuticals
SCPH
$577K 0.03%
101,713
-1,370,814
-93% -$7.02M
TECH icon
218
Bio-Techne
TECH
$11.2B
$562K 0.03%
10,103
-31
-0.3% -$1.66K
CVX icon
219
Chevron
CVX
$381B
$552K 0.03%
3,557
– –
IEX icon
220
IDEX
IEX
$17.3B
$544K 0.03%
3,343
-17
-0.5% -$2.87K
J icon
221
Jacobs Solutions
J
$17.2B
$531K 0.03%
3,545
– –
TFX icon
222
Teleflex
TFX
$5.94B
$522K 0.03%
4,263
-580
-12% -$70.3K
EW icon
223
Edwards Lifesciences
EW
$53.2B
$513K 0.03%
6,592
-36
-0.5% -$2.81K
XOM icon
224
ExxonMobil
XOM
$661B
$499K 0.03%
4,429
– –
KEX icon
225
Kirby Corp
KEX
$6.95B
$459K 0.03%
5,505
-81
-1% -$8.14K
7 8
9
10 11

Similar funds

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return

Rice Hall James & Associates's Q3 2025 Portfolio in Review

As of Q3 2025, Rice Hall James & Associates held 261 positions worth $1.83B, down 1.2% from $1.86B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Rice Hall James & Associates withdrew a net $201M in Q3 2025, closing 13 positions and reducing 199 holdings. Its most notable exit was Olo Inc, an estimated $4.38M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 31% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in Sportradar worth $21.5M.

  • Rice Hall James & Associates's largest Q3 2025 buy was Sportradar: 799,217 shares worth $21.5M.
  • Rice Hall James & Associates added most to Shift4 in Q3 2025, an estimated $22.6M increase.
  • Rice Hall James & Associates's biggest Q3 2025 reduction was Verona Pharma, cutting an estimated $58.7M.
  • Rice Hall James & Associates fully exited Olo Inc in Q3 2025, selling an estimated $4.38M.
  • Rice Hall James & Associates's ten largest holdings make up 25% of its $1.83B portfolio in Q3 2025.
  • Rice Hall James & Associates opened 14 new positions and closed 13 in Q3 2025.
  • Rice Hall James & Associates's portfolio value fell 1.2% quarter-over-quarter to $1.83B.

Based on Rice Hall James & Associates's 13F filing for Q3 2025, filed 16 Oct 2025.